Evidence map›Paper›PMID 24944198›Full record

ArticleAmerican journal of physiology. Cell physiology2014

Specific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs.

Ling X Zhang, Megan DeNicola, Xin Qin, Jianfeng Du, Julio Ma, Yu Tina Zhao, Shougang Zhuang, Paul Y Liu, Lei Wei, Gangjian Qin and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Ling X ZhangDepartment of Medicine, Rhode Island Hospital, Brown Medical School, Brown University, Providence, Rhode Island;
Megan DeNicolaDepartment of Surgery, Boston University Medical School, Boston University, Roger Williams Medical Center, Providence, Rhode Island;
Xin QinDepartment of Surgery, Boston University Medical School, Boston University, Roger Williams Medical Center, Providence, Rhode Island;
Jianfeng DuDepartment of Surgery, Boston University Medical School, Boston University, Roger Williams Medical Center, Providence, Rhode Island;
Julio MaDepartment of Surgery, Boston University Medical School, Boston University, Roger Williams Medical Center, Providence, Rhode Island;
Yu Tina ZhaoDepartment of Medicine, Rhode Island Hospital, Brown Medical School, Brown University, Providence, Rhode Island; tzhao@bu.edu.
Shougang ZhuangDepartment of Medicine, Rhode Island Hospital, Brown Medical School, Brown University, Providence, Rhode Island;
Paul Y LiuDepartment of Surgery, Boston University Medical School, Boston University, Roger Williams Medical Center, Providence, Rhode Island;
Lei WeiDepartment of Orthopaedics, Rhode Island Hospital, Brown Medical School, Brown University, Providence, Rhode Island.
Gangjian QinFeinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois; and.
Yaoliang TangDepartment of Medicine, University of Cincinnati, Cincinnati, Ohio;
Ting C ZhaoDepartment of Surgery, Boston University Medical School, Boston University, Roger Williams Medical Center, Providence, Rhode Island;
Providence College · USBoston University · USBrown University · USRhode Island Hospital · USNorthwestern University · USUniversity of Cincinnati · US

Funding

Histone Deacetylase Inhibition: A Novel Approach to CardioprotectionR01HL089405 · NHLBI · ROGER WILLIAMS MEDICAL CENTER · PI ZHAO, TING C · 2009 to 2020
$3.4M
p38 acetylation: Novel signaling mechanisms and myocardial protectionR01HL115265 · NHLBI · ROGER WILLIAMS MEDICAL CENTER · PI ZHAO, TING C · 2013 to 2016
$1.6M
NHLBI NIH HHS R01 HL-089405NHLBI NIH HHS R01 HL089405NHLBI NIH HHS R01 HL-115265NHLBI NIH HHS R01 HL115265
6 · The paper itself

Abstract

We have recently shown that in vivo inhibition of histone deacetylase (HDAC) stimulates endogenous myocardial regeneration in infarcted hearts (Zhang L et al. J Pharmacol Exp Ther 341: 285-293, 2012). Furthermore, our observation demonstrates that HDAC inhibition promotes cardiogenesis, which is associated with HDAC4 reduction. However, it remains unknown as to whether specific inhibition of HDAC4 modulates cardiac stem cells (CSCs) to facilitate myocardial repair and to preserve cardiac performance. c-kit(+) CSCs were isolated from adult mouse hearts and were transfected with HDAC4 siRNA to knockdown HDAC4 of c-kit(+) CSCs. The transfection of HDAC4 siRNA caused a marked reduction of HDAC4 mRNA and proteins in c-kit(+) CSCs. Mouse myocardial infarction (MI) was created to assess the effect of HDAC4 inhibition in c-kit(+) CSCs on myocardial regeneration in vivo when cells were introduced into MI hearts. Transplantation of HDAC4 siRNA-treated c-kit(+) CSCs into MI hearts improved ventricular function, attenuated ventricular remodeling, and promoted CSC-derived regeneration and neovascularization. Furthermore, Ki67 and BrdU positively proliferative myocytes increased in MI hearts receiving HDAC4 siRNA-treated c-kit(+) CSCs compared with MI hearts engrafted with control siRNA-treated c-kit(+) CSCs. In addition, compared with MI hearts engrafted with control adenoviral GFP-infected c-kit(+) CSCs, MI hearts receiving adenoviral HDAC4-infected c-kit(+) CSCs exhibited attenuated cardiac functional recovery, CSC-derived regeneration, and neovascularization, which was accompanied with adverse ventricular remodeling and decrease in Ki67 and BrdU positively proliferative myocytes. HDAC4 inhibition facilitated c-kit(+) CSCs into the differentiation into cardiac lineage commitments in vitro, while HDAC4 overexpression attenuated c-kit(+) CSC-derived cardiogenesis. Our results indicate that HDAC4 inhibition promotes CSC-derived cardiac regeneration and improves the restoration of cardiac function.

Indexed as

RegenerationStem Cell TransplantationAnimalsBiomarkersCell DifferentiationCell LineageCell ProliferationCells, CulturedDisease Models, AnimalGene Knockdown TechniquesHistone DeacetylasesKi-67 AntigenMaleMiceMyocardial InfarctionMyocardiumBiomarkersHdac5 protein, mouseHistone DeacetylasesKi-67 AntigenProto-Oncogene Proteins c-kitHDAC4heartmyocardial infarctionregenerationstem cells

Identifiers

PMID24944198
PMCPMC4137141
OpenAlexW2064781260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.